TARGETED MOLECULAR THERAPIES IN A NOVEL MOUSE MODEL OF HUMAN OESOPHAGEAL CANCER
Grant number: 1056240 | Funding period: 2013 - 2016
Oesophageal cancer is the most rapidly increasing malignancy in Western society. This disease often presents in advanced stages with poor response to established medical and surgical therapies. Our aim is to develop a novel mouse model of oesophageal cancer, allowing us to tailor cancer-inhibiting molecular treatments to individual patients by predicting therapeutic success or resistance with the use of cellular markers identified in our animal mode.